Cargando…
The State of Immunotherapy in Hepatobiliary Cancers
Hepatobiliary cancers, including hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and gallbladder carcinoma (GBC), are lethal cancers with limited therapeutic options. Curative-intent treatment typically involves surgery, yet recurrence is common and many patients present with advanced dise...
Autores principales: | Ilyas, Farhan Z., Beane, Joal D., Pawlik, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393650/ https://www.ncbi.nlm.nih.gov/pubmed/34440865 http://dx.doi.org/10.3390/cells10082096 |
Ejemplares similares
-
Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022) -
Hereditary Pancreatic and Hepatobiliary Cancers
por: Haddad, Ashraf, et al.
Publicado: (2011) -
Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond
por: Contreras, Carlo M., et al.
Publicado: (2020) -
Textbook outcomes in hepatobiliary and pancreatic surgery
por: Tsilimigras, Diamantis I, et al.
Publicado: (2021) -
Emerging Trends in Immunotherapy for Adult Sarcomas
por: Husain, Marium, et al.
Publicado: (2023)